Our mission is to enable pharmaceutical and biotechnology companies to bring more cell and gene therapies to patients, by dramatically increasing the efficiency of viral vector production and reducing the cost of manufacturing. 64x Bio was founded by world renowned scientists and experts in gene therapy from Harvard and the Wyss Institute. Our rapidly growing and cross disciplinary team consists of creative bioengineers and synthetic biologists working alongside data scientists to create cutting-edge solutions to problems in gene therapy.
The Platform Program Manager will establish 64x Bio’s program management function and work closely with the R&D team, senior leadership, and industry partners to drive the success of our VectorSelect™ platform. PMP certification and previous experience in a dynamic startup environment preferred.